Abstract
Because inflammation and oxidative stress are closely related, oxidative stress cannot be ignored when considering pathologic conditions associated with inflammation-based Kawasaki disease (KD). KD pathogenesis is triggered by certain unknown infectious factors that activate one or multiple inflammation pathways via intricately intertwined cytokine cascades. Overproduction of reactive oxygen species from activated inflammation pathways increases oxidative stress in the body and results in an endless vicious cycle between inflammation reactions and reactive oxygen, which presumably underlies the diffuse vasculitis formed during acute KD. Although vascular inflammation and oxidative stress can be rapidly suppressed by treatment during the acute phase, they may persist in various forms for a long time. This has recently been identified as a concern in late KD. Generally, the presence of vascular inflammation and oxidative stress impairs blood vessels, leading to atherosclerosis onset, a widely recognized risk (Li et al., Atherosclerosis 237(1):208–219, 2014). This chapter will focus on determining whether the same is valid for blood vessels in late KD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sies H. What is oxidative stress? In: Kency Jr JF, editor. Oxidative stress and vascular disease. Boston: Kluwer Academic Publishers; 2000. p. 1–8. 10.1007/978-1-4615-4649-8_1.
Takahashi K, Oharaseki T, Naoe S, Wakayama M, Yokouchi Y. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int. 2005;47(3):305–10. http://dx.doi.org/10.1111/j.1442-200x.2005.02049.x. PMID:15910456.
Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86(5):494–501. http://dx.doi.org/. 10.1161/01.RES.86.5.494. PMID:10720409.
Kumar U, Chen J, Sapoznikhov V, Canteros G, White BH, Sidhu A. Overexpression of inducible nitric oxide synthase in the kidney of the spontaneously hypertensive rat. Clin Exp Hypertens. 2005;27(1):17–31. http://dx.doi.org/10.1081/CEH-200044249. PMID:15773227.
Takatsuki S, Ito Y, Takeuchi D, Hoshida H, Nakayama T, Matsuura H, Saji T. IVIG reduced vascular oxidative stress in patients with Kawasaki disease. Circ J. 2009;73(7):1315–8. http://doi.org/10.1253/circj.CJ-07-0635. PMID:19436119.
Yahata T, Suzuki C, Hamaoka A, Fujii M, Hamaoka K. Dynamics of reactive oxygen metabolites and biological antioxidant potential in the acute stage of Kawasaki disease. Circ J. 2011;75(10):2453–9. http://dx.doi.org/10.1253/circj.CJ-10-0605. PMID:21785226.
Shen CT, Wang NK. Antioxidants may mitigate the deterioration of coronary arteritis in patients with Kawasaki disease unresponsive to high-dose intravenous gamma-globulin. Pediatr Cardiol. 2001;22(5):419–22. http://dx.doi.org/10.1007/s002460010268. PMID:11526424.
Steer KA, Wallace TM, Bolton CH, Hartog M. Aspirin protects low density lipoprotein from oxidative modification. Heart. 1997;77(4):333–7. http://dx.doi.org/10.1136/hrt.77.4.333. PMID:9155612.
Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, RAISE study group investigators, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet. 2012;379(9826):1613–20. http://dx.doi.org/10.1016/S0140-6736(11)61930-2. PMID:22405251.
Suzuki H, Terai M, Hamada H, Honda T, Suenaga T, Takeuchi T, et al. Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin. Pediatr Infect Dis J. 2011;30(10):871–6. http://dx.doi.org/10.1097/INF.0b013e318220c3cf. PMID:21587094.
Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, et al. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet. 2014;383(9930):1731–8. http://dx.doi.org/10.1016/S0140-6736(13)62298-9. PMID:24572997.
Niboshi A, Hamaoka K, Sakata K, Yamaguchi N. Endothelial dysfunction in adult patients with a history of Kawasaki disease. Eur J Pediatr. 2008;167(2):189–96. http://dx.doi.org/10.1007/s00431-007-0452-9. PMID:17345094.
Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362(6423):801–9. http://dx.doi.org/10.1038/362801a0. PMID:8479518.
Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320(14):915–24. PMID:2648148.
Kawashima S, Yokoyama M. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24(6):998–1005. http://dx.doi.org/10.1161/01.ATV.0000125114.88079.96. PMID:15001455.
Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002;105(14):1656–62. http://dx.doi.org/10.1161/01.CIR.0000012748.58444.08. PMID:11940543.
Takahashi K, Oharaseki T, Naoe S. Pathological study of postcoronary arteritis in adolescents and young adults: with reference to the relationship between sequelae of Kawasaki disease and atherosclerosis. Pediatr Cardiol. 2001;22(2):138–42. http://dx.doi.org/10.1007/s002460010180. PMID:11178671.
Mitani Y, Ohashi H, Sawada H, Ikeyama Y, Hayakawa H, Takabayashi S, et al. In vivo plaque composition and morphology in coronary artery lesions in adolescents and young adults long after Kawasaki disease: a virtual histology-intravascular ultrasound study. Circulation. 2009;119(21):2829–36. http://dx.doi.org/10.1161/CIRCULATIONAHA.108.818609. PMID:19451352.
Liu Y, Onouchi Z, Sakata K, Ikuta K. An experimental study on the role of smooth muscle cells in the pathogenesis of atherosclerosis of the coronary arteritis. J Jpn Pediatr Soc. 1996;100:1453–8.
Hamaoka-Okamoto A, Suzuki C, Yahata T, Ikeda K, Nagi-Miura N, Ohno N, et al. The involvement of the vasa vasorum in the development of vasculitis in animal model of Kawasaki disease. Pediatr Rheumatol Online J. 2014;12(1):12. http://dx.doi.org/10.1186/1546-0096-12-12. PMID:24678599.
Deng YB, Xiang HJ, Chang Q, Li CL. Evaluation by high-resolution ultrasonography of endothelial function in brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Circ J. 2002;66(10):908–12. http://dx.doi.org/10.1253/circj.66.908. PMID:12381083.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Japan
About this chapter
Cite this chapter
Yahata, T., Hamaoka, K. (2017). Oxidative Stress in Kawasaki Disease. In: Saji, B., Newburger, J., Burns, J., Takahashi, M. (eds) Kawasaki Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56039-5_38
Download citation
DOI: https://doi.org/10.1007/978-4-431-56039-5_38
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-56037-1
Online ISBN: 978-4-431-56039-5
eBook Packages: MedicineMedicine (R0)